Health Care & Life Sciences » Pharmaceuticals | Canopy Growth Corp.

Canopy Growth Corp. | Cash Flow

Fiscal year is April-March. All values CAD Thousands.
2015
2016
2017
2018
2019
Net Income before Extraordinaries
9,346.50
3,496.00
16,658.00
54,134.00
670,094
Depreciation, Depletion & Amortization
646.50
2,256.00
6,064.00
20,486.00
46,918
Other Funds
507.10
72.00
-
-
337,995
Funds from Operations
13,750.20
35,134.00
57,776.00
52,987.00
272,863
Changes in Working Capital
2,858.00
22,688.00
30,683.00
28,519.00
262,168
Net Operating Cash Flow
10,892.20
12,446.00
27,093.00
81,506.00
535,031
Capital Expenditures
15,385.60
13,121.00
29,532.00
178,169.00
Sale of Fixed Assets & Businesses
-
1,054.00
11,230.00
7,075.00
Purchase/Sale of Investments
-
236.00
-
48,618.00
Net Investing Cash Flow
15,385.60
12,303.00
18,302.00
223,465.00
Issuance/Reduction of Debt, Net
1,875.60
1,938.00
2,801.00
1,512.00
Net Financing Cash Flow
45,633.50
18,700.00
132,098.00
525,849.00
Net Change in Cash
19,355.80
6,049.00
86,703.00
220,878.00
Free Cash Flow
26,272.70
25,567.00
56,484.00
257,543.00
Deferred Taxes & Investment Tax Credit
-
-
-
1,593.00
12,318
Net Assets from Acquisitions
-
-
-
3,753.00
Change in Capital Stock
43,250.80
20,566.00
129,297.00
527,361.00

About Canopy Growth

View Profile
Address
1 Hershey Drive
Smith Falls Ontario K7A 0A8
Canada
Employees -
Website http://www.canopygrowth.com
Updated 07/08/2019
Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules, and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite.